Your session is about to expire
← Back to Search
Sublingual Lobeline for Methamphetamine Addiction
Study Summary
This trial will test if it's safe to give lobeline under the tongue, and how it affects the body.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- My health checks, including heart tests and blood work, show I can safely participate.My BMI is between 18 and 30.You must test negative for drugs during the screening process and before being admitted into the trial.My BMI is between 18 and 30.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could I potentially join this trial as a participant?
"This clinical trial aims to recruit 12 individuals, aged 18-45 years old with methamphetamine dependence. To be considered for the study, participants must have a healthy BMI of between 18 and 30 as well as need to provide evidence of abstinence via drug screening tests."
Are recruitment efforts underway for this research undertaking?
"As verified on clinicaltrials.gov, this experiment is no longer enrolling participants; it was initially posted in February 2006 and last edited in January 2017. However, 18 other trials are currently accepting patients for their studies."
Does this treatment have the stamp of approval from the Food and Drug Administration?
"The safety of this treatment is rated at a 1 due to the limited clinical evidence available, as it's currently in Phase 1 trials."
Does this trial accommodate patients who are over sixty years old?
"Individuals who are between 18 and 45 years old may be eligible for enrollment in this research trial."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger